Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Clostridium Vaccine market size was valued at USD 605.32 million in 2022 and is expected to expand at a CAGR of 3.57% during the forecast period, reaching USD 747.25 million by 2028.
Clostridium spp. belongs to firmicutes, which is a large class of normal facultative anaerobic bacteria in intestine and can produce spores. Dozens of Clostridium strains have been reported in previous studies. Some of them were used to prevent, diagnose and treat relative human diseases, and others were demonstrated to be related to diseases including antibiotic-associated diarrhea, pseudomembranous colitis and so on.
Clostridium Vaccine Growth Drivers
According to Eurostat data, in 2020, more than one fifth (20.6 %) of the EU population was aged 65 and over. The share of people aged 80 years or above in the EU's population is projected to have a two-and-a-half-fold increase between 2020 and 2100, from 5.9 % to 14.6 %. Currently, around 8% of the population in South America is 65 years of age or older, still well below Europe's 20.6%. By 2050, however, this figure is expected double to 17.5%, and to exceed 30% by the end of the century. There are several known risk factors for Clostridium difficile infection, including race, sex and age. For example, women and people over 65 have a higher risk of developing CDI, because the diversity of intestinal microflora decreases. The aging of population will become one of the main factors of various diseases, thus promoting the growth of Clostridium Vaccine demand.
Britain, Spain, France and Italy are among the largest sheep meat producers in Europe. Britain has the most ewes in Europe, while Ireland is the largest net exporter of sheep meat in the European Union. In addition to sheep meat production, there are also a large number of dairy sheep producing milk and cheese in Europe. Clostridium disease is the most common cause of sudden death in sheep of all ages. Examples of clostridial diseases include polyposis (Clostridium perfringens type d), lamb dysentery (Clostridium perfringens type b), percussion (Clostridium perfringens type c), C. septicum, C. novyi and botulinum. For clostridial diseases, it is not bacteria that cause the disease, but the toxins they produce. Mutton and goat milk production is a very important farm enterprise in Europe, which plays a key role in society, economy and environment in many "underdeveloped areas". The demand of sheep industry will promote the development of Clostridium Vaccine industry.
Region Overview:
From 2023-2028, UK is estimated to witness robust growth prospects.
Company Overview:
The top three companies are MSD Animal Health, Zoetis, Ceva Santé Animale, with the revenue market share of 40.23%, 36.59%, 7.56% in 2019.
MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA. Through commitment to the Science of Healthier Animals, it offers a wide range of veterinary products and services. Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.
Zoetis Inc. is an American drug company, one of the world's largest producer of medicine and vaccinations for pets and livestock. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries.
Segmentation Overview:
Among different product types, With 8 Actives Ingredients segment is anticipated to contribute the largest market share in 2028.
This report elaborates on the market size, market characteristics, and market growth of the Clostridium Vaccine industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Clostridium Vaccine. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Clostridium Vaccine Market Report Include:
Market Size Estimates: Clostridium Vaccine market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Clostridium Vaccine market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Clostridium Vaccine market
Segment Market Analysis: Clostridium Vaccine market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Clostridium Vaccine market situations and prospects in major and top regions and countries
Clostridium Vaccine Market
Clostridium Vaccine Industry Chain: Clostridium Vaccine market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Clostridium Vaccine Industry News, Policies by regions
Clostridium Vaccine Industry Porters Five Forces Analysis
Key players in the global Clostridium Vaccine market are covered in Chapter 2:
Ceva Santé Animale
Pfizer
Zoetis
Valneva
MSD Animal Health
Boehringer Ingelheim
In Chapter 6 and Chapter 9, on the basis of types, the Clostridium Vaccine market from 2018 to 2028 is primarily split into:
With 8 Actives Ingredients
With 7 actives Ingredients
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Clostridium Vaccine market from 2018 to 2028 covers:
Human
Veterinary
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Clostridium Vaccine market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Clostridium Vaccine industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Clostridium Vaccine market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Clostridium Vaccine industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Clostridium Vaccine market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Clostridium Vaccine market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Clostridium Vaccine market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Clostridium spp. belongs to firmicutes, which is a large class of normal facultative anaerobic bacteria in intestine and can produce spores. Dozens of Clostridium strains have been reported in previous studies. Some of them were used to prevent, diagnose and treat relative human diseases, and others were demonstrated to be related to diseases including antibiotic-associated diarrhea, pseudomembranous colitis and so on.
Clostridium Vaccine Growth Drivers
According to Eurostat data, in 2020, more than one fifth (20.6 %) of the EU population was aged 65 and over. The share of people aged 80 years or above in the EU's population is projected to have a two-and-a-half-fold increase between 2020 and 2100, from 5.9 % to 14.6 %. Currently, around 8% of the population in South America is 65 years of age or older, still well below Europe's 20.6%. By 2050, however, this figure is expected double to 17.5%, and to exceed 30% by the end of the century. There are several known risk factors for Clostridium difficile infection, including race, sex and age. For example, women and people over 65 have a higher risk of developing CDI, because the diversity of intestinal microflora decreases. The aging of population will become one of the main factors of various diseases, thus promoting the growth of Clostridium Vaccine demand.
Britain, Spain, France and Italy are among the largest sheep meat producers in Europe. Britain has the most ewes in Europe, while Ireland is the largest net exporter of sheep meat in the European Union. In addition to sheep meat production, there are also a large number of dairy sheep producing milk and cheese in Europe. Clostridium disease is the most common cause of sudden death in sheep of all ages. Examples of clostridial diseases include polyposis (Clostridium perfringens type d), lamb dysentery (Clostridium perfringens type b), percussion (Clostridium perfringens type c), C. septicum, C. novyi and botulinum. For clostridial diseases, it is not bacteria that cause the disease, but the toxins they produce. Mutton and goat milk production is a very important farm enterprise in Europe, which plays a key role in society, economy and environment in many "underdeveloped areas". The demand of sheep industry will promote the development of Clostridium Vaccine industry.
Region Overview:
From 2023-2028, UK is estimated to witness robust growth prospects.
Company Overview:
The top three companies are MSD Animal Health, Zoetis, Ceva Santé Animale, with the revenue market share of 40.23%, 36.59%, 7.56% in 2019.
MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA. Through commitment to the Science of Healthier Animals, it offers a wide range of veterinary products and services. Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.
Zoetis Inc. is an American drug company, one of the world's largest producer of medicine and vaccinations for pets and livestock. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries.
Segmentation Overview:
Among different product types, With 8 Actives Ingredients segment is anticipated to contribute the largest market share in 2028.
This report elaborates on the market size, market characteristics, and market growth of the Clostridium Vaccine industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Clostridium Vaccine. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Clostridium Vaccine Market Report Include:
Market Size Estimates: Clostridium Vaccine market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Clostridium Vaccine market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Clostridium Vaccine market
Segment Market Analysis: Clostridium Vaccine market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Clostridium Vaccine market situations and prospects in major and top regions and countries
Clostridium Vaccine Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Clostridium Vaccine Industry Chain: Clostridium Vaccine market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Clostridium Vaccine Industry News, Policies by regions
Clostridium Vaccine Industry Porters Five Forces Analysis
Key players in the global Clostridium Vaccine market are covered in Chapter 2:
Ceva Santé Animale
Pfizer
Zoetis
Valneva
MSD Animal Health
Boehringer Ingelheim
In Chapter 6 and Chapter 9, on the basis of types, the Clostridium Vaccine market from 2018 to 2028 is primarily split into:
With 8 Actives Ingredients
With 7 actives Ingredients
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Clostridium Vaccine market from 2018 to 2028 covers:
Human
Veterinary
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Clostridium Vaccine market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Clostridium Vaccine industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Clostridium Vaccine market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Clostridium Vaccine industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Clostridium Vaccine market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Clostridium Vaccine market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Clostridium Vaccine market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
